ArticlesCompetitive Benchmarking: How to Spot Gaps and Drive Smarter Growth
ArticlesDeloitte study: eight out of ten commercial real estate companies expect revenue growth in 2026
ArticlesTop 100 City Destinations Index 2025: Driving Growth and Innovation
ArticlesThe competitive advantage that transforms your business
Articles2026 consumer trends and industry insights [Webinar]
InterviewsPUTTING ROMANIAN CORPORATE COMPANIES ON THE INTERNATIONAL BUSINESS SCENE
InterviewsOUR EDGE WILL COME FROM BEING THE MOST DIGITALIZED WHOLESALER IN ROMANIA
InterviewsCOFFEE IS OUR LOVE LANGUAGE
InterviewsBUILDING THE FUTURE OF ENERGY: ENEVO GROUP’S ONE-STOP-SHOP MODEL FOR THE ENERGY TRANSITION
InterviewsROOTED IN ROMANIA, BUILT TO DELIVER TECHNOLOGY FOR THE WORLD - EVANTAGE SOFT MODEL FOR GLOBAL IMPACT
NewsThe New S-Class: Refinement, Innovation and 140 Years of History
NewsSchneider Electric to become the Official Energy Technology Partner of McLaren Racing
News2026 consumer trends and industry insights
NewsRomania and Italy, the first ones applying handling fee on parcels below 150 euros from outside the EU. Customs duty comes next
NewsVodafone Foundation invests another 1.5 million lei in equipping neonatology units in Romania

Johnson & Johnson Announces Leading Candidate for COVID-19 Vaccine

Copyright © Shutterstock

Johnson & Johnson Announces Leading Candidate for COVID-19 Vaccine

JOHNSON & JOHNSON ROMANIA SRL

1 Apr 2020

A referral partnership with the US Department of Health and Human Services and commitment to provide one billion global vaccines for emergency pandemic control

Johnson & Johnson and BARDA are committed to investing over $ 1 billion together in research and development of the new coronavirus vaccine; The company expects to initiate phase 1 clinical trials for the candidate vaccine no later than September 2020.

For more information, please see the Romanian version of the article, here.

Authors

foto

JOHNSON & JOHNSON ROMANIA SRL

Comert al produselor farmaceutice.

See all published materials

View company profile

Tags : COVID-19 Vaccine , emergency pandemic control , candidate vaccine , coronavirus

© 2026, DoingBusiness.ro

Update cookies preferences